By X. Mufassa. Oklahoma State University Tulsa. 2018.
Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine order 30 caps himplasia mastercard wicked herbals amped. Pegylated liposomal doxorubicin discount himplasia 30 caps with mastercard himalaya herbals india, rituximab, cyclophosphamide, vin- cristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin’s lym- phoma: results of therapy and correlates of response. Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. Lim ST, Karim R, Nathwani BN, AIDS-related Burkitt’s lymphoma versus diffuse large-cell lymphoma in the pre- highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. Highly effective treatment of AIDS-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Persistent panhypogammaglobulinemia after CHOP-Rituximab for HIV-related lym- phoma. Evolution of the Causes of Death among HIV+ Patients between 2000 and 2010: Results of the French National Survey “ANRS EN20 Mortalité 2010”. Mounier N, Katlama C, Costagliola D, Chichmanian RM, Spano JP. Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin’s lymphoma in East Africa. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV- associated Burkitt lymphoma. Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma : comparison of results in human immunodeficiency virus-infected and noninfected patients. Two-weekly or 3-weekly CHOP chemotherapy with or without etopo- side for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Effects of combination chemotherapy and HAART on immune parameters in HIV-1 associated lymphoma. A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Chemotherapy for HIV-associated non-Hodgkin’s lymphoma in combination with HAART. Stem cell mobilization in HIV seropositive patients with lymphoma. Effect of highly active antiretroviral therapy on biomarkers of B-lympho- cyte activation and inflammation. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, pred- nisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Bortezomib in plasmablastic lymphoma: a case report and review of the litera- ture. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. Characterization of immunologic and virological parameters in HIV- infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy. Immune recovery after autologous stem cell transplantation is not differ- ent for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin’s lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.
The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study 30caps himplasia fast delivery herbs lung cancer. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients proven himplasia 30 caps phoenix herbals 50x. Pioglitazone reduces atherogenic outcomes in type 2 diabetic patients. Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetes. Clinical predictors of glycosylated hemoglobin response to thiazolidinedione therapy. Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary. Renoprotection provided by losartan in combination with pioglitazone is superior to renoprotection provided by losartan alone in patients with type 2 diabetic nephropathy. Retrospective medication use evaluation of pioglitazone in Type II diabetes mellitus at a county, hospital district. Distal upper and lower limb fractures associated with thiazolidinedione use. Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes. Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. Effects of pioglitazone and insulin on tight glycaemic control assessed by the continuous glucose monitoring system - A monocentric, parallel-cohort study. Clinical Drug Investigation (New Zealand) 2005;25(May). Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus. Beneficial effects of combined treatment with rosiglitazone and exercise on 40 cardiovascular risk factors in patients with type 2 diabetes. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration. Rosiglitazone decreases C- reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT). Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity. Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population. Economic effect of augmentation strategies in patients with type 2 diabetes initiated on sulfonylureas. Insulin-sensitizing antihyperglycaemic medications are associated with better outcome in patients with diabetes undergoing cardiac stress testing. The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions. Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Glycemic response to newly initiated diabetes therapies. Monitoring the Safety of Pioglitazone Results of a Prescription-Event Monitoring Study of 12 772 Patients in England.
Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol generic himplasia 30 caps otc rumi herbals, fenoterol cheap himplasia 30 caps fast delivery herbals for hot flashes, isoproterenol, and epinephrine in patients with asthma. Comparison of fenoterol and terbutaline administered by intermittent positive pressure breathing. A comparative double-blind study of the bronchodilator effects and side effects of inhaled fenoterol and terbutaline administered in equipotent doses. Fenoterol is as effective as terbutaline in the pear- shaped spacer. A comparison of terbutaline and fenoterol unit dose vials in treating children with acute asthmatic attacks. Comparison of Bricanyl Turbuhaler and Berotec dry powder inhaler. The efficacy of terbutaline and fenoterol aerosols on adult exercise- induced asthma. Comparative effects of pirbuterol acetate, metaproterenol, and placebo aerosols on pulmonary function and incidence of cardiac ectopy. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol. Chester EH, Doggett WE, Montenegro HD, Schwartz HJ, Jones PK. Quick-relief medications for asthma Page 63 of 113 Final Report Update 1 Drug Effectiveness Review Project 101. A comparative study of the aerosolized bronchodilators, isoproterenol, metaproterenol and terbutaline in asthma. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. Wraight JM, Smith AD, Cowan JO, Flannery EM, Herbison GP, Taylor DR. Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate. Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma. Therapy with fenoterol and ipratropium bromide powder]. Pharmacological similarities and differences between beta -agonists. Case-control study of severe life threatening asthma (SLTA) in a developing community. Quick-relief medications for asthma Page 64 of 113 Final Report Update 1 Drug Effectiveness Review Project Appendix A. Search strategies Original Search Database: EBM Reviews - Cochrane Central Register of Controlled Trials <1st Quarter 2006> Search Strategy: -------------------------------------------------------------------------------- 1 Salmeterol. Quality assessment methods for drug class reviews for the Drug Effectiveness Review Project This appendix outlines the methods used by the Oregon Evidence-based Practice Center, based at Oregon Health & Science University, and any subcontracting Evidence-based Practice Centers in producing drug class reviews for the Drug Effectiveness Review Project. The procedure outlined in this appendix ensures that the reviews created by using these methods are scientifically defensible, reproducible, and well documented. These methods were adapted from the Procedure Manual developed by the Methods Work Group of the United States Preventive Services Task Force (version 1. All included studies and systematic reviews are assessed for quality and assigned a rating of good, fair, or poor. Studies that have a fatal flaw in 1 or more criteria are rated poor quality. Studies that meet all criteria are rated good quality. As the fair-quality category is broad, studies with this rating vary in their strengths and weaknesses: The results of some fair quality studies are likely to be valid, while others are only probably valid. A poor-quality trial is not valid: Its results are at least as likely to reflect flaws in the study design as a true difference between the compared drugs. Controlled Trials Assessment of Internal Validity 1.
10 of 10 - Review by X. Mufassa
Votes: 196 votes
Total customer reviews: 196